Open AccessDoes Ginkgo biloba Reduce the Risk of Cardiovascular Events?
Author(s) -
Lewis H. Kuller,
Diane G. Ives,
Annette L. Fitzpatrick,
Michelle C. Carlson,
Carla Mercado,
Oscar L. López,
Gregory L. Burke,
Curt D. Furberg,
Steven T. DeKosky
Publication year - 2009
Publication title -
circulation cardiovascular quality and outcomes
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.692
H-Index - 87
eISSN - 1941-7713
pISSN - 1941-7705
DOI - 10.1161/circoutcomes.109.871640
Subject(s) - ginkgo biloba , medicine , placebo , vascular disease , stroke (engine) , myocardial infarction , clinical trial , disease , pharmacology , pathology , engineering , alternative medicine , mechanical engineering
Cardiovascular disease (CVD) was a preplanned secondary outcome of the Ginkgo Evaluation of Memory Study. The trial previously reported that Ginkgo biloba had no effect on the primary outcome, incident dementia.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom